Reifschneider, G.
Hôpital Necker-Enfants Malades · Cleveland Clinic · Inserm · Université de Lille · Universitat de Girona · Hospital Universitari Arnau de Vilanova · Centre Hospitalier Universitaire de Lille · Humboldt-Universität zu Berlin · AB Science (France) · Jena University Hospital · Hospital Universitari de Girona Doctor Josep Trueta · Institut des Maladies Génétiques Imagine · Lille Neurosciences & Cognition · Freie Universität Berlin · Charité – Universitätsmedizin Berlin
3 papers on CoChat
Most cited papers
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified
Quality of life in 1000 patients with early relapsing–remitting multiple sclerosis
Putzki, N., Fischer, J., Gottwald, K., Reifschneider, G., Ries, S., Siever, A., Hoffmann, F., Käfferlein, W., Kausch, U., Liedtke, M., et al. (2009) · European Journal of Neurology
Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life
Cited by 80
- Verified · note
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 74
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free